Case of a Patient with Glycogen Storage Disease Type Ib and Acute Myeloid Leukemia
Author Information
Author(s): Thomas Schroeder, Barbara Hildebrandt, Ertan Mayatepek, Ulrich Germing, Rainer Haas
Primary Institution: Heinrich-Heine-University, Düsseldorf, Germany
Hypothesis
Does long-term treatment with granulocyte colony-stimulating factor increase the risk of acute myeloid leukemia in patients with glycogen storage disease type Ib?
Conclusion
Regular bone marrow examinations should be conducted for patients with glycogen storage disease type Ib on long-term G-CSF treatment due to the increased risk of developing acute myeloid leukemia.
Supporting Evidence
- The patient had a history of glycogen storage disease type Ib and received G-CSF for 14 years.
- Cytogenetic analysis revealed monosomy 7 and translocation t(3;8)(q26;q24).
- The patient developed acute myeloid leukemia after long-term G-CSF treatment.
Takeaway
A patient with a rare disease developed leukemia after many years of treatment, showing that the treatment might have caused the cancer.
Methodology
Case report detailing the patient's medical history, treatment, and outcomes.
Potential Biases
Potential bias due to the retrospective nature of the case report.
Limitations
The findings are based on a single case, limiting generalizability.
Participant Demographics
28-year-old Turkish male.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website